2020 · BMC infectious diseases · open access
Urine collection in cervical cancer screening - analytical comparison of two HPV DNA assays
Tranberg et al.
The finding, in our words
First-void urine self-collection for HPV testing showed good agreement with cervical samples using the COBAS assay (kappa 0.66) but only moderate agreement with CLART (kappa 0.47). The COBAS assay achieved 63.9% sensitivity and 96.5% specificity with far fewer invalid results than CLART (1.8% versus 26.9%), and 42% of women preferred urine sampling, indicating that urine-based HPV testing is an acceptable decentralised option but requires improved analytical performance before implementation for non-participants.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.